ID

36780

Beschreibung

Inhibiting COMT in Parkinson's Disease; ODM derived from: https://clinicaltrials.gov/show/NCT02070887

Link

https://clinicaltrials.gov/show/NCT02070887

Stichworte

Versionen (1)
  1. 07.06.19 07.06.19 -
Rechteinhaber

See clinicaltrials.gov

Hochgeladen am

7. Juni 2019

DOI

Für eine Beantragung loggen Sie sich ein.

Lizenz

Creative Commons BY 4.0
Modell Kommentare :

Hier können Sie das Modell kommentieren. Über die Sprechblasen an den Itemgruppen und Items können Sie diese spezifisch kommentieren.

Zurück zu Modell Kommentaren
Itemgroup Kommentare für :

Item Kommentare für :

Um Formulare herunterzuladen müssen Sie angemeldet sein. Bitte loggen Sie sich ein oder registrieren Sie sich kostenlos.

Eligibility Parkinson's Disease NCT02070887

Englisch

Eligibility Parkinson's Disease NCT02070887

1 Formulare  
Inclusion Criteria
Beschreibung

Inclusion Criteria

Alias
UMLS CUI
C1512693
age 60 - 75 years,
Beschreibung

Age

Datentyp

boolean

Alias
UMLS CUI [1]
C0001779
caucasian ethnicity,
Beschreibung

Caucasians

Datentyp

boolean

Alias
UMLS CUI [1]
C0043157
diagnosed pd by uk brain bank criteria,
Beschreibung

Parkinson Disease

Datentyp

boolean

Alias
UMLS CUI [1]
C0030567
hoehn & yahr scale 2 - 3,
Beschreibung

Hoehn and Yahr Scale

Datentyp

boolean

Alias
UMLS CUI [1]
C4274667
fertile females have to use contraception
Beschreibung

Childbearing Potential Contraceptive methods

Datentyp

boolean

Alias
UMLS CUI [1,1]
C3831118
UMLS CUI [1,2]
C0700589
group 1: medication with stalevo® (l-dopa/ddi + entacapone)
Beschreibung

Stalevo | Levodopa | DOPA Decarboxylase Inhibitors | entacapone

Datentyp

boolean

Alias
UMLS CUI [1]
C1434452
UMLS CUI [2]
C0023570
UMLS CUI [3]
C0598272
UMLS CUI [4]
C0165921
group 2: medication with madopar® or sinemet® (l-dopa/ddi)
Beschreibung

Madopar | Sinemet | Levodopa | DOPA Decarboxylase Inhibitors

Datentyp

boolean

Alias
UMLS CUI [1]
C0065502
UMLS CUI [2]
C0074559
UMLS CUI [3]
C0023570
UMLS CUI [4]
C0598272
Exclusion Criteria
Beschreibung

Exclusion Criteria

Alias
UMLS CUI
C0680251
methotrexate therapy during the last 12 months,
Beschreibung

Methotrexate

Datentyp

boolean

Alias
UMLS CUI [1]
C0025677
treatment with tolcapone
Beschreibung

tolcapone

Datentyp

boolean

Alias
UMLS CUI [1]
C0246330
vitamin b6, b12 and/or folic acid supplementation during last 6 months,
Beschreibung

Vitamin B6 supplementation | Vitamin B12 supplementation | Folic acid supplementation

Datentyp

boolean

Alias
UMLS CUI [1]
C4524021
UMLS CUI [2]
C4524262
UMLS CUI [3]
C0556110
pregnancy,
Beschreibung

Pregnancy

Datentyp

boolean

Alias
UMLS CUI [1]
C0032961
intention to become pregnant during the course of the study,
Beschreibung

Pregnancy, Planned

Datentyp

boolean

Alias
UMLS CUI [1]
C0032992
breast feeding,
Beschreibung

Breast Feeding

Datentyp

boolean

Alias
UMLS CUI [1]
C0006147
other clinically relevant concomitant disease states by discretion of the investigator
Beschreibung

Comorbidity Relevant Clinical

Datentyp

boolean

Alias
UMLS CUI [1,1]
C0009488
UMLS CUI [1,2]
C2347946
UMLS CUI [1,3]
C0205210
known or suspected non-compliance, drug or alcohol abuse,
Beschreibung

Compliance behavior Lacking | Compliance behavior Lacking Suspected | Substance Use Disorders

Datentyp

boolean

Alias
UMLS CUI [1,1]
C1321605
UMLS CUI [1,2]
C0332268
UMLS CUI [2,1]
C1321605
UMLS CUI [2,2]
C0332268
UMLS CUI [2,3]
C0750491
UMLS CUI [3]
C0038586
inability to follow the procedures of the study, e.g. due to language problems, psychological disorders, dementia or confusional state of the subject,
Beschreibung

Protocol Compliance Unable | Etiology Language problems | Etiology Mental disorders | Etiology Dementia | Etiology Confusion

Datentyp

boolean

Alias
UMLS CUI [1,1]
C0525058
UMLS CUI [1,2]
C1299582
UMLS CUI [2,1]
C0015127
UMLS CUI [2,2]
C1405458
UMLS CUI [3,1]
C0015127
UMLS CUI [3,2]
C0004936
UMLS CUI [4,1]
C0015127
UMLS CUI [4,2]
C0497327
UMLS CUI [5,1]
C0015127
UMLS CUI [5,2]
C0009676
participation in another study with investigational drug within the 30 days preceding and during the present study,
Beschreibung

Study Subject Participation Status | Investigational New Drugs

Datentyp

boolean

Alias
UMLS CUI [1]
C2348568
UMLS CUI [2]
C0013230
enrolment of the investigator, his/her family members, employees and other dependent persons.
Beschreibung

Enrollment Investigator | Enrollment Family member | Enrollment Employee | Enrollment Persons dependent

Datentyp

boolean

Alias
UMLS CUI [1,1]
C1516879
UMLS CUI [1,2]
C0035173
UMLS CUI [2,1]
C1516879
UMLS CUI [2,2]
C0086282
UMLS CUI [3,1]
C1516879
UMLS CUI [3,2]
C0599987
UMLS CUI [4,1]
C1516879
UMLS CUI [4,2]
C0027361
UMLS CUI [4,3]
C3244310
Zum Seitenanfang zurückkehren

Ähnliche Modelle

Eligibility Parkinson's Disease NCT02070887

1 Formulare
Name
Typ
Description | Question | Decode (Coded Value)
Datentyp
Alias
Item Group
C1512693 (UMLS CUI)
Age
Item
age 60 - 75 years,
boolean
C0001779 (UMLS CUI [1])
Caucasians
Item
caucasian ethnicity,
boolean
C0043157 (UMLS CUI [1])
Parkinson Disease
Item
diagnosed pd by uk brain bank criteria,
boolean
C0030567 (UMLS CUI [1])
Hoehn and Yahr Scale
Item
hoehn & yahr scale 2 - 3,
boolean
C4274667 (UMLS CUI [1])
Childbearing Potential Contraceptive methods
Item
fertile females have to use contraception
boolean
C3831118 (UMLS CUI [1,1])
C0700589 (UMLS CUI [1,2])
Stalevo | Levodopa | DOPA Decarboxylase Inhibitors | entacapone
Item
group 1: medication with stalevo® (l-dopa/ddi + entacapone)
boolean
C1434452 (UMLS CUI [1])
C0023570 (UMLS CUI [2])
C0598272 (UMLS CUI [3])
C0165921 (UMLS CUI [4])
Madopar | Sinemet | Levodopa | DOPA Decarboxylase Inhibitors
Item
group 2: medication with madopar® or sinemet® (l-dopa/ddi)
boolean
C0065502 (UMLS CUI [1])
C0074559 (UMLS CUI [2])
C0023570 (UMLS CUI [3])
C0598272 (UMLS CUI [4])
Item Group
C0680251 (UMLS CUI)
Methotrexate
Item
methotrexate therapy during the last 12 months,
boolean
C0025677 (UMLS CUI [1])
tolcapone
Item
treatment with tolcapone
boolean
C0246330 (UMLS CUI [1])
Vitamin B6 supplementation | Vitamin B12 supplementation | Folic acid supplementation
Item
vitamin b6, b12 and/or folic acid supplementation during last 6 months,
boolean
C4524021 (UMLS CUI [1])
C4524262 (UMLS CUI [2])
C0556110 (UMLS CUI [3])
Pregnancy
Item
pregnancy,
boolean
C0032961 (UMLS CUI [1])
Pregnancy, Planned
Item
intention to become pregnant during the course of the study,
boolean
C0032992 (UMLS CUI [1])
Breast Feeding
Item
breast feeding,
boolean
C0006147 (UMLS CUI [1])
Comorbidity Relevant Clinical
Item
other clinically relevant concomitant disease states by discretion of the investigator
boolean
C0009488 (UMLS CUI [1,1])
C2347946 (UMLS CUI [1,2])
C0205210 (UMLS CUI [1,3])
Compliance behavior Lacking | Compliance behavior Lacking Suspected | Substance Use Disorders
Item
known or suspected non-compliance, drug or alcohol abuse,
boolean
C1321605 (UMLS CUI [1,1])
C0332268 (UMLS CUI [1,2])
C1321605 (UMLS CUI [2,1])
C0332268 (UMLS CUI [2,2])
C0750491 (UMLS CUI [2,3])
C0038586 (UMLS CUI [3])
Protocol Compliance Unable | Etiology Language problems | Etiology Mental disorders | Etiology Dementia | Etiology Confusion
Item
inability to follow the procedures of the study, e.g. due to language problems, psychological disorders, dementia or confusional state of the subject,
boolean
C0525058 (UMLS CUI [1,1])
C1299582 (UMLS CUI [1,2])
C0015127 (UMLS CUI [2,1])
C1405458 (UMLS CUI [2,2])
C0015127 (UMLS CUI [3,1])
C0004936 (UMLS CUI [3,2])
C0015127 (UMLS CUI [4,1])
C0497327 (UMLS CUI [4,2])
C0015127 (UMLS CUI [5,1])
C0009676 (UMLS CUI [5,2])
Study Subject Participation Status | Investigational New Drugs
Item
participation in another study with investigational drug within the 30 days preceding and during the present study,
boolean
C2348568 (UMLS CUI [1])
C0013230 (UMLS CUI [2])
Enrollment Investigator | Enrollment Family member | Enrollment Employee | Enrollment Persons dependent
Item
enrolment of the investigator, his/her family members, employees and other dependent persons.
boolean
C1516879 (UMLS CUI [1,1])
C0035173 (UMLS CUI [1,2])
C1516879 (UMLS CUI [2,1])
C0086282 (UMLS CUI [2,2])
C1516879 (UMLS CUI [3,1])
C0599987 (UMLS CUI [3,2])
C1516879 (UMLS CUI [4,1])
C0027361 (UMLS CUI [4,2])
C3244310 (UMLS CUI [4,3])
Zum Seitenanfang zurückkehren 

Kontakt

Benutzen Sie dieses Formular für Rückmeldungen, Fragen und Verbesserungsvorschläge.

Mit * gekennzeichnete Felder sind notwendig.

Hilfe

Benötigen Sie Hilfe bei der Suche? Um mehr Details zu erfahren und die Suche effektiver nutzen zu können schauen Sie sich doch das entsprechende Video auf unserer Tutorial Seite an.

Zum Video